Cargando…
Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition
Excessive genomic instability coupled with abnormalities in DNA repair pathways induces high levels of ‘replication stress’ when cancer cells propagate. Rather than hampering cancer cell proliferation, novel treatment strategies are turning their attention towards targeting cell cycle checkpoint kin...
Autores principales: | Sundararajan, Vignesh, Tan, Tuan Zea, Lim, Diana, Peng, Yanfen, Wengner, Antje Margret, Ngoi, Natalie Yan Li, Jeyasekharan, Anand D, Tan, David Shao Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107453/ https://www.ncbi.nlm.nih.gov/pubmed/36373784 http://dx.doi.org/10.1002/path.6032 |
Ejemplares similares
-
The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer
por: Jiang, Huayong, et al.
Publicado: (2016) -
Exploiting replicative stress in gynecological cancers as a therapeutic strategy
por: Ngoi, Natalie YL, et al.
Publicado: (2020) -
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression
por: Di Benedetto, Anna, et al.
Publicado: (2017) -
Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer
por: Liu, Kang, et al.
Publicado: (2021) -
Targeting the ATR-CHK1 Axis in Cancer Therapy
por: Rundle, Stuart, et al.
Publicado: (2017)